Meritxell Sabido

Frankfurter Str. 250
Darmstadt, HE 64293, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the Global MAPLE-MS Pharmacovigilance Program.

Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the Global MAPLE-MS Pharmacovigilance Program.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 25, 2025

Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the Global MAPLE-MS Pharmacovigilance Program.

Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the Global MAPLE-MS Pharmacovigilance Program.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 30, 2025

Insights into adherence to cladribine tablets in the real world in multiple countries: results from patient support programs.

Insights into adherence to cladribine tablets in the real world in multiple countries: results from patient support programs.

Journal: Therapeutic advances in neurological disorders

Published: June 03, 2025

Evaluating Data Quality by Proxy: Can We Evaluate All Dimensions of the European Medicines Agency Data Quality Framework for Registry-Based Post-Authorization Safety Studies?

Evaluating Data Quality by Proxy: Can We Evaluate All Dimensions of the European Medicines Agency Data Quality Framework for Registry-Based Post-Authorization Safety Studies?

Journal: Pharmacoepidemiology and drug safety

Published: March 04, 2025

Disease-modifying therapy during pregnancy and postpartum relapse activity in women with multiple sclerosis undergoing assisted reproductive technology treatment: a nationwide cohort study.

Disease-modifying therapy during pregnancy and postpartum relapse activity in women with multiple sclerosis undergoing assisted reproductive technology treatment: a nationwide cohort study.

Journal: BMJ neurology open

Published: February 26, 2025

A Systematic Review of Algorithms for Identifying Pediatric Neurodevelopmental Outcomes.

A Systematic Review of Algorithms for Identifying Pediatric Neurodevelopmental Outcomes.

Journal: Pharmacoepidemiology and drug safety

Published: December 19, 2024

Algorithms to Identify Major Congenital Malformations in Routinely Collected Healthcare Data: A Systematic Review.

Algorithms to Identify Major Congenital Malformations in Routinely Collected Healthcare Data: A Systematic Review.

Journal: Drug safety

Published: December 19, 2024

Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION Study.

Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION Study.

Journal: Clinical epidemiology

Published: May 31, 2024

Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force.

Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 23, 2023

Improving Data Collection in Pregnancy Safety Studies: Towards Standardisation of Data Elements in Pregnancy Reports from Public and Private Partners, A Contribution from the ConcePTION Project.

Improving Data Collection in Pregnancy Safety Studies: Towards Standardisation of Data Elements in Pregnancy Reports from Public and Private Partners, A Contribution from the ConcePTION Project.

Journal: Drug safety

Published: November 15, 2023

The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis.

The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis.

Journal: Current medical research and opinion

Published: September 07, 2023

Drug Utilization Studies in Pregnant Women for Newly Licensed Medicinal Products: A Contribution from IMI ConcePTION.

Drug Utilization Studies in Pregnant Women for Newly Licensed Medicinal Products: A Contribution from IMI ConcePTION.

Journal: Journal of pregnancy

Published: August 25, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026